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background:  Over the past decade, the development of novel management strategies has resulted in improved outcomes among patients 
hospitalized with ST-segment myocardial infarction (STEMI). The aim of the present study was to compare temporal trends in the outcomes of 
smokers versus non-smokers admitted with STEMI between 2000 and 2010.
methods:  We evaluated time-dependent changes in the clinical characteristics, management strategies, and all-cause mortality of STEMI patients 
who were enrolled between 2000 and 2010, categorized as smokers (n=2399) and non-smokers (n=3069). We divided the survey periods into early 
(2000-2004) and late (2006-2010).
results:  A total of 5468 STEMI patients were enrolled in study. Both smokers and nonsmokers who were enrolled in the late survey period received 
more evidence-based therapies (primary PCI, guideline-based medications) (p<0.001 for all). There was a significant reduction in the risk of 1-year 
all-cause mortality only among non-smokers (HR=0.74 CI 95% 0.60-0.89, p=0.002), whereas smokers who were enrolled in more recent survey 
periods did not display a significant risk reduction (HR=1.01 CI 95% 0.72-1.4, p=0.95).
Conclusion: Survival following STEMI among smokers has not improved over the past decade despite corresponding changes in management 
strategies. Future trials should focus on reducing the risk in smokers
